Skip to main content
. 2021 Jan 28;36(1):525–534. doi: 10.1080/14756366.2021.1874946

Figure 3.

Figure 3.

Cysteine is required for the bioactivation of nitrite to NO in human platelets. Washed human platelets (3 × 108/mL, 100 µL) were incubated with indicated compounds. The concentration of NaNO2 was 10 µM where added. L-Cysteine (Cys) was added at final concentrations of 100 µM or 200 µM. The incubation time was 5 min. Sodium nitroprusside (SNP) was used at 1 µM (1 min) and served as positive control. Some samples were pre-incubated for 10 min with the CA inhibitor acetazolamide (ACZ) at 200 µM, or with the sGC inhibitor ODQ at 20 µM; then NaNO2 and Cys were added and the samples were incubated for 10 min. All samples were processed for Western blot analysis of VASPSer239 phosphorylation, with actin blots serving as loading control. Blots were scanned and analysed densitometrically using NIH Image J software for uncalibrated optical density (graph). Results are presented as mean with standard deviation from quadruplicate analyses. Asterisk (*) indicate p values < 0.05 compared to control. Statistical analysis was performed by one-way ANOVA and Student’s t-test.